RNAi-mediated knock-down of arylamine N-acetyltransferase-1 expression induces E-cadherin up-regulation and cell-cell contact growth inhibition.
Arylamine N-acetyltransferase-1 (NAT1) is an enzyme that catalyzes the biotransformation of arylamine and hydrazine substrates. It also has a role in the catabolism of the folate metabolite p-aminobenzoyl glutamate. Recent bioinformatics studies have correlated NAT1 expression with various cancer su...
Enregistré dans:
Auteurs principaux: | Jacky M Tiang, Neville J Butcher, Carleen Cullinane, Patrick O Humbert, Rodney F Minchin |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2f26c16d738f419d93ff2c4fd6b2f83a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
LMNA knock-down affects differentiation and progression of human neuroblastoma cells.
par: Giovanna Maresca, et autres
Publié: (2012) -
Directed nickel-catalyzed regio- and diastereoselective arylamination of unactivated alkenes
par: Leipeng Xie, et autres
Publié: (2021) -
Progression of oral squamous cell carcinoma accompanied with reduced E-cadherin expression but not cadherin switch.
par: Takashi Hashimoto, et autres
Publié: (2012) -
Synthesis of arylamines and N-heterocycles by direct catalytic nitrogenation using N2
par: Kai Wang, et autres
Publié: (2021) -
Differential Gene Expression in Bladder Tumors from Workers Occupationally Exposed to Arylamines
par: Ramya T. Kolli, et autres
Publié: (2021)